The effect of recombinant LH on embryo quality: A randomized controlled trial in women with poor ovarian reserve

Human Reproduction

Volumn 27, Issue 1, 2012, Pages 244-250

  Musters, A M ^a   Van Wely, M ^a   Mastenbroek, S ^a   Kaaijk, E M ^b   Repping, S ^a   Van Der Veen, F ^a   Mochtar, M H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Centre for Reproductive Medicine   (Netherlands)

Author keywords

embryo quality; IVF outcome; ovarian stimulation; recombinant LH

Indexed keywords

FOLLITROPIN; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; TRIPTORELIN;

ADULT; ANTRAL FOLLICLE COUNT; ARTICLE; CONTROLLED OVARIAN HYPERSTIMULATION; CONTROLLED STUDY; EMBRYO; EMBRYO QUALITY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MORPHOLOGY; OUTCOME ASSESSMENT; OVARY FOLLICLE; OVARY FUNCTION; OVARY HYPERSTIMULATION; POOR OVARIAN RESERVE; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

EID: 83755205829     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der371     Document Type: Article

References (49)

1. Acevedo B, Sanchez M, Gomez JL, Cuadros J, Ricciarelli E, Hernandez ER. Luteinizing hormone supplementation increases pregnancy rates in gonadotropin-releasing hormone antagonist donor cycles. Fertil Steril 2004;82:343-347. (Pubitemid 39092033)
2. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 2002;77:328-336. (Pubitemid 34083557)
3. Barrenetxea G, Agirregoikoa JA, Jimenez MR, de Larruzea AL, Ganzabal T, Carbonero K. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Fertil Steril 2008;89:546-553. (Pubitemid 351335051)
4. Beckers NG, Macklon NS, Eijkemans MJ, Fauser BC. Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging. Fertil Steril 2002;78:291-297. (Pubitemid 34831729)
5. Bosch E, Labarta E, Crespo J, Simon C, Remohi J, Pellicer A. Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis. Fertil Steril 2011;95:1031-1036.
6. Coomarasamy A, Afnan M, Cheema D, van der Veen F, Bossuyt PM, van Wely M. Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis. Hum Reprod 2008;23:310-315. (Pubitemid 351651234)
7. Croucher CA, Lass A, Margara R, Winston RM. Predictive value of the results of a first in-vitro fertilization cycle on the outcome of subsequent cycles. Hum Reprod 1998;13:403-408.
8. de Boer EJ, den Tonkelaar I, te Velde ER, Burger CW, Klip H, vanLeeuwen FE; OMEGA-project group. A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril 2002;77:978-985. (Pubitemid 34497166)
9. De Placido G, Alviggi C, Perino A, Strina I, Lisi F, Fasolino A, De PR, Ranieri A, Colacurci N, Mollo A. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod 2005;20:390-396. (Pubitemid 40277606)
10. Durnerin CI, Erb K, Fleming R, Hillier H, Hillier SG, Howles CM, Hugues JN, Lass A, Lyall H, Rasmussen P et al. Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation. Hum Reprod 2008;23:421-426. (Pubitemid 351651260)
11. Efron B. Better bootstrap confidence intervals. J Am Stat Assoc 1987; 82:171-185.
12. El-Toukhy T, Khalaf Y, Hart R, Taylor A, Braude P. Young age does not protect against the adverse effects of reduced ovarian reserve-an eight year study. Hum Reprod 2002;17:1519-1524. (Pubitemid 34661801)
13. Fabregues F, Creus M, Penarrubia J, Manau D, Vanrell JA, Balasch J. Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age. Fertil Steril 2006;85:925-931.
14. Ferraretti AP, Gianaroli L, Magli MC, D'angelo A, Farfalli V, Montanaro N. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril 2004;82:1521-1526. (Pubitemid 39611376)
15. Filicori M, Cognigni GE. Efficiency and efficacy of exogenous gonadotrophins containing LH activity. Reprod Biomed Online 2003;7:254-255.
16. Filicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, de Fatis CT. Low-dose human chorionic gonadotropin therapy can improve sensitivity to exogenous follicle-stimulating hormone in patients with secondary amenorrhea. Fertil Steril 1999;72:1118-1120.
17. Filicori M, Cognigni GE, Tabarelli C, Pocognoli P, Taraborrelli S, Spettoli D, Ciampaglia W. Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. J Clin Endocrinol Metab 2002;87:1156-1161. (Pubitemid 36121081)
18. Frattarelli JL, Bergh PA, Drews MR, Sharara FI, Scott RT. Evaluation of basal estradiol levels in assisted reproductive technology cycles. Fertil Steril 2000;74:518-524.
19. Frattarelli JL, Levi AJ, Miller BT, Segars JH. Prognostic use of mean ovarian volume in in vitro fertilization cycles: a prospective assessment. Fertil Steril 2004;82:811-815. (Pubitemid 39346422)
20. Garcia JE, Jones GS, Acosta AA, Wright G Jr. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II, 1981. Fertil Steril 1983;39:174-179. (Pubitemid 13195405)
21. Gutman G, Barak V, Maslovitz S, Amit A, Lessing JB, Geva E. Recombinant luteinizing hormone induces increased production of ovarian follicular adiponectin in vivo: implications for enhanced insulin sensitivity. Fertil Steril 2009;91:1837-1841.
22. Hellberg D, Waldenstrom U, Nilsson S. Defining a poor responder in in vitro fertilization. Fertil Steril 2004;82:488-490. (Pubitemid 39092062)
23. Hsieh YY, Chang CC, Tsai HD. Antral follicle counting in predicting the retrieved oocyte number after ovarian hyperstimulation. J Assist Reprod Genet 2001;18:320-324.
24. Jacobs SL, Metzger DA, Dodson WC, Haney AF. Effect of age on response to human menopausal gonadotropin stimulation. J Clin Endocrinol Metab 1990;71:1525-1530. (Pubitemid 120032770)
25. Jenkins JM, DaviesDW, Devonport H, Anthony FW, Gadd SC,Watson RH, Masson GM. Comparison of 'poor responders' with 'good responders' using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilisation. Hum Reprod 1991;6:918-921.
26. Keay SD, Liversedge NH, Mathur RS, Jenkins JM. Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 1997;104:521-527. (Pubitemid 27240414)
27. Kovacs P, Kovats T, Kaali SG. Results with early follicular phase recombinant luteinizing hormone supplementation during stimulation for in vitro fertilization. Fertil Steril 2010;93:475-479.
28. Lawson R, El-Toukhy T, Kassab A, Taylor A, Braude P, Parsons J, Seed P. Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis. Hum Reprod 2003;18:527-533. (Pubitemid 36329319)
29. MarrsR,MeldrumD,Muasher S, SchoolcraftW,Werlin L,Kelly E.Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reprod Biomed Online 2004;8:175-182.
30. Mastenbroek S, Twisk M, van Echten-Arends J, Sikkema-Raddatz B, Korevaar JC, Verhoeve HR, Vogel NE, Arts EG, de Vries JW, Bossuyt PM et al. In vitro fertilization with preimplantation genetic screening. N Engl J Med 2007;357:9-17. (Pubitemid 47026730)
31. Mathews TJ, Brady E, Hamilton BE. Delayed childbearing: more women are having their first child later in life. NCHS Data Brief 2009;21:1-8.
32. Matorras R, Prieto B, Exposito A, Mendoza R, Crisol L, Herranz P, Burgues S. Mid-follicular LH supplementation in women aged 35-39 years undergoing ICSI cycles: a randomized controlled study. Reprod Biomed Online 2009;19:879-887.
33. Mochtar MH, van der Veen F, Ziech M, van Wely M. Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev 2007; CD005070.
34. Muttukrishna S, Suharjono H, McGarrigle H, Sathanandan M. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients? BJOG 2004;111:1248-1253. (Pubitemid 39472171)
35. Nyboe Andersen A, Humaidan P, Fried G, Hausken J, Antila L, Bangsboll S, Rasmussen PE, Lindenberg S, Bredkjaer HE, Meinertz H. Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial. Hum Reprod 2008; 23:427-434. (Pubitemid 351651237)
36. Pellicer A, Lightman A, Diamond MP, Russell JB, DeCherney AH. Outcome of in vitro fertilization in women with low response to ovarian stimulation. Fertil Steril 1987;47:812-815. (Pubitemid 17078302)
37. Pellicer A, Mari M, de los Santos MJ, Simon C, Remohi J, Tarin JJ. Effects of aging on the human ovary: the secretion of immunoreactive alpha-inhibin and progesterone. Fertil Steril 1994;61:663-668. (Pubitemid 24114358)
38. Pezzuto A, Ferrari B, Coppola F, Nardelli GB. LH supplementation in down-regulated women undergoing assisted reproduction with baseline low serum LH levels. Gynecol Endocrinol 2009;26:1-7.
39. Puissant F, Van Rysselberge M, Barlow P, Deweze J, Leroy F. Embryo scoring as a prognostic tool in IVF treatment. Hum Reprod 1987;2:705-708.
40. Sallam HN, Ezzeldin F, Agameya AF, Rahman AF, El-Garem Y. Defining poor responders in assisted reproduction. Int J Fertil Womens Med 2005;50:115-120. (Pubitemid 46638708)
41. Scott RT Jr, Hofmann GE. Prognostic assessment of ovarian reserve. Fertil Steril 1995;63:1-11.
42. Steer CV, Mills CL, Tan SL, Campbell S, Edwards RG. The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme. Hum Reprod 1992;7:117-119.
43. Sullivan MW, Stewart-Akers A, Krasnow JS, Berga SL, Zeleznik AJ. Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation. J Clin Endocrinol Metab 1999;84:228-232. (Pubitemid 29036707)
44. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 2003;9:61-76. (Pubitemid 36305584)
45. Tesarik J, Mendoza C. Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence. Hum Reprod 2002; 17:3129-3137. (Pubitemid 35469262)
46. Toner JP, Philput CB, Jones GS, Muasher SJ. Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55:784-791.
47. Ulug U, Ben-Shlomo I, Turan E, Erden HF, Akman MA, Bahceci M. Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles. Reprod Biomed Online 2003;6:439-443. (Pubitemid 36849804)
48. van Wely M, Kwan I, Burt AL, Thomas J, Vail A, Veen F, van der Veen F, Al-Inany HG. Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. Cochrane Database Syst Rev 2011;2:CD005354.
49. Veeck LL. The morphological assessment of human oocytes and early conception. In: Keel BA, Webster BW (eds). Handbook of the Laboratory Diagnosis and Treatment of Infertility. Boston: CRC Press, 1990, 353-369.